Company news

Hyperfine, Inc. news in 2026

Hyperfine, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness

October 22, 2026

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million

October 8, 2026

Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026

October 8, 2026

Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets

September 28, 2026

Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents

September 15, 2026

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference

August 31, 2026

Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans

August 26, 2026

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

August 20, 2026

Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

August 6, 2026

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

August 6, 2026

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

July 29, 2026

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

July 23, 2026

Hyperfine Announces European Launch of Next-Generation Swoop® System

July 1, 2026

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

June 21, 2026

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

June 18, 2026

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

May 26, 2026

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

May 21, 2026

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

May 12, 2026

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

May 6, 2026

Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution

April 28, 2026

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

April 28, 2026

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

April 8, 2026

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

March 17, 2026

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

March 5, 2026

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities

January 27, 2026

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

January 20, 2026

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

January 15, 2026

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

January 12, 2026

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

January 9, 2026

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

January 6, 2026

Calls in 2026

Decks in 2026